Showing 20 of 27 recruiting trials for “autoimmune-pancreatitis”
Long-term Impact of NMDAR Encephalitis, Level 3
RecruitingNCT07477015 ↗
Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis
👨⚕️ Raffaele Iorio, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 1 site📅 Started Jul 2025View details ↗
RecruitingNCT06955286 ↗
Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion
Belimumab in Autoimmune Hepatitis
👨⚕️ Gideon Hirschfield, MB BChir, PhD, University Health Network, Toronto📍 5 sites📅 Started Dec 2024View details ↗
Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis
Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)
A Study of SIPLIZUMAB in AILD and LT Patients
👨⚕️ Elizabeth Verna, MD, Columbia University Irving Medical Center/ New York Presbyterian Hospital📍 1 site📅 Started Sep 2024View details ↗
RecruitingNCT07133113 ↗
Medium-term Effects of Treatments in Autoimmune Encephalitis
Enrolling by InvitationNCT06061341 ↗
TruGraf Liver Gene Expression Serial Test
👨⚕️ Jason Wellen, MD, Washington University School of Medicine📍 2 sites📅 Started Aug 2024View details ↗
RecruitingNCT06519162 ↗
Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients
RecruitingNCT05810480 ↗
PredIcting SterOid DepeNdEnt LivEr InjuRy with Polyreactive Immunoglobulin G
RecruitingNCT06078098 ↗
Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage
RecruitingNCT06019975 ↗
FDG-PET in the Diagnosis of Autoimmune Encephalitis
RecruitingNCT05785793 ↗
Autoimmune Hepatitis Cohort in China
👨⚕️ Xiong Ma, MD,PHD, Renji Hospital, School of Medicine, Shanghai Jiao Tong University📍 1 site📅 Started Feb 2023View details ↗
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis
Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection
RecruitingNCT06173076 ↗
A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis
👨⚕️ Chun-Hong Shen, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China📍 1 site📅 Started May 2022View details ↗
RecruitingNCT05750498 ↗
A-LiNK: Improving Outcomes in Autoimmune Liver Disease
👨⚕️ Amy E Taylor, MD, Children's Hospital Medical Center, Cincinnati📍 8 sites📅 Started Apr 2022View details ↗
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →